Gartung A

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : Enhancing cancer immunotherapy via inhibition of soluble epoxide hydrolase - Kelly_2024_Proc.Natl.Acad.Sci.U.S.A_121_e2314085121
Author(s) : Kelly AG , Wang W , Rothenberger E , Yang J , Gilligan MM , Kipper FC , Attaya A , Gartung A , Hwang SH , Gillespie MJ , Bayer RL , Quinlivan KM , Torres KL , Huang S , Mitsiades N , Yang H , Hammock BD , Panigrahy D
Ref : Proc Natl Acad Sci U S A , 121 :e2314085121 , 2024
Abstract : Kelly_2024_Proc.Natl.Acad.Sci.U.S.A_121_e2314085121
ESTHER : Kelly_2024_Proc.Natl.Acad.Sci.U.S.A_121_e2314085121
PubMedSearch : Kelly_2024_Proc.Natl.Acad.Sci.U.S.A_121_e2314085121
PubMedID: 38330013

Title : Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19? - Panigrahy_2020_Cancer.Metastasis.Rev__
Author(s) : Panigrahy D , Gilligan MM , Huang S , Gartung A , Cortes-Puch I , Sime PJ , Phipps RP , Serhan CN , Hammock BD
Ref : Cancer Metastasis Rev , : , 2020
Abstract : Panigrahy_2020_Cancer.Metastasis.Rev__
ESTHER : Panigrahy_2020_Cancer.Metastasis.Rev__
PubMedSearch : Panigrahy_2020_Cancer.Metastasis.Rev__
PubMedID: 32385712

Title : Suppression of chemotherapy-induced cytokine\/lipid mediator surge and ovarian cancer by a dual COX-2\/sEH inhibitor - Gartung_2019_Proc.Natl.Acad.Sci.U.S.A_116_1698
Author(s) : Gartung A , Yang J , Sukhatme VP , Bielenberg DR , Fernandes D , Chang J , Schmidt BA , Hwang SH , Zurakowski D , Huang S , Kieran MW , Hammock BD , Panigrahy D
Ref : Proc Natl Acad Sci U S A , 116 :1698 , 2019
Abstract : Gartung_2019_Proc.Natl.Acad.Sci.U.S.A_116_1698
ESTHER : Gartung_2019_Proc.Natl.Acad.Sci.U.S.A_116_1698
PubMedSearch : Gartung_2019_Proc.Natl.Acad.Sci.U.S.A_116_1698
PubMedID: 30647111